Institutional Investor's Pro-Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Sentiment In Q3 2019 | Finance Recorder
Sentiment for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) institutional sentiment increased to 1.02 in 2019 Q3. Its up 0.15, from 0.87 in 2019Q2. The ratio increased, as 85 investment managers increased or started new equity positions, while 83 cut down and sold holdings in Allscripts Healthcare Solutions Inc. The investment managers in our partner's database now have: 167.31 million shares, down from 169.65 million shares in 2019Q2. Also, the number of investment managers holding Allscripts Healthcare Solutions Inc in their top 10 equity positions was flat from 2 to 2 for the same number . Sold All: 17 Reduced: 66 Increased: 62 New Position: 23.
Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. The company has market cap of $1.55 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. It has a 7.64 P/E ratio. The companyÂ's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.
The stock decreased 3.82% or $0.38 during the last trading session, reaching $9.57. About 2.18 million shares traded or 25.34% up from the average. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has risen 5.78% since December 15, 2018 and is uptrending. It has outperformed by 5.78% the S&P500.
Analysts await Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to report earnings on February, 20. They expect $0.14 EPS, down 12.50 % or $0.02 from last year's $0.16 per share. MDRX's profit will be $22.73M for 17.09 P/E if the $0.14 EPS becomes a reality. After $0.14 actual EPS reported by Allscripts Healthcare Solutions, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.
Adirondack Research & Management Inc. holds 4.16% of its portfolio in Allscripts Healthcare Solutions, Inc. for 433,920 shares. Penn Capital Management Co Inc owns 1.80 million shares or 2.06% of their US portfolio. Moreover, Paradigm Capital Management Inc Ny has 1.88% invested in the company for 1.91 million shares. The Vermont-based Prentiss Smith & Co Inc has invested 1.58% in the stock. Fuller & Thaler Asset Management Inc., a California-based fund reported 8.68 million shares.
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Coverage
Ratings analysis reveals 33% of Allscripts's analysts are positive. Out of 3 Wall Street analysts rating Allscripts, 1 give it "Buy", 0 "Sell" rating, while 2 recommend "Hold". The lowest target is $1100 while the high is $14. The stock's average target of $12.17 is 27.17% above today's ($9.57) share price. MDRX was included in 5 notes of analysts from June 20, 2019. The rating was maintained by Cowen & Co with "Buy" on Thursday, June 20.
More notable recent Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news were published by: Nasdaq.com which released: "AllScripts Healthcare (MDRX) Beats Q3 Earnings Estimates - Nasdaq" on November 04, 2019, also Finance.Yahoo.com with their article: "Should You Be Concerned About Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Historical Volatility? - Yahoo Finance" published on June 10, 2019, Businesswire.com published: "EPSi Announces Release of Advanced Analytics Offering - Business Wire" on December 03, 2019. More interesting news about Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) were released by: Finance.Yahoo.com and their article: "One Thing To Remember About The Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Share Price - Yahoo Finance" published on November 18, 2019 as well as Globenewswire.com 's news article titled: "Allscripts announces fourth quarter and 2018 full-year results - GlobeNewswire" with publication date: February 21, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Sentiment for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) institutional sentiment increased to 1.02 in Q3 2019. Its up 0.15, from 0.87 in 2019Q2. The ratio is better, as
More News in Health
Market Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the worldwide Global Cardiology Electrodes Market 2019 Analysis, Size, Share, Growth,
The global "EMG Disposable Medical Electrodes Market" research report highlights the need for the up-to-date market data for the business management that will offer development and profitability of the global EMG Disposable Medical Electrodes market.
For sufferers with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI), and whole breast irradiation (WBI), based on a study explained at the annual San Antonio Breast
One of the people for whom the memory of the epidemic's darkest days is still fresh is Craig Lenti, a New York City-based media producer. Lenti moved to Manhattan in 1996 at age 18 to attend
Market Research Report has developed new advance system known as Orthopedic Medical Imaging market , which presents detailed information on the major competitors GE Healthcare, Siemens Healthineers, Philips Healthcare, Hitachi, Carestream Health, EOS imaging, PLANMED
THOUSANDS of woman could soon be cured of breast cancer in just ONE WEEK with a groundbreaking test to spot the disease. The new test - being trialled by cancer experts in the UK - will